These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 7039924)

  • 1. Pharmacokinetics of drugs in obesity.
    Abernethy DR; Greenblatt DJ
    Clin Pharmacokinet; 1982; 7(2):108-24. PubMed ID: 7039924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug disposition in obese humans. An update.
    Abernethy DR; Greenblatt DJ
    Clin Pharmacokinet; 1986; 11(3):199-213. PubMed ID: 3524955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacokinetics of drugs in obesity. An update.
    Cheymol G
    Clin Pharmacokinet; 1993 Aug; 25(2):103-14. PubMed ID: 8403734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosage adjustments for antibacterials in obese patients: applying clinical pharmacokinetics.
    Bearden DT; Rodvold KA
    Clin Pharmacokinet; 2000 May; 38(5):415-26. PubMed ID: 10843460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of obesity on drug disposition.
    Blouin RA; Kolpek JH; Mann HJ
    Clin Pharm; 1987 Sep; 6(9):706-14. PubMed ID: 3315402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations.
    Bartelink IH; Rademaker CM; Schobben AF; van den Anker JN
    Clin Pharmacokinet; 2006; 45(11):1077-97. PubMed ID: 17048973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of the neonate.
    Currin MR
    S Afr Med J; 1979 Jul; 56(3):101-5. PubMed ID: 386526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug pharmacokinetics in the obese.
    Cheymol G
    Fundam Clin Pharmacol; 1988; 2(3):239-56. PubMed ID: 3042569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of obesity on pharmacokinetics implications for drug therapy.
    Cheymol G
    Clin Pharmacokinet; 2000 Sep; 39(3):215-31. PubMed ID: 11020136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of acute and chronic exercise on hepatic drug metabolism.
    Døssing M
    Clin Pharmacokinet; 1985; 10(5):426-31. PubMed ID: 3899456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using pharmacokinetics in drug therapy. VII: Pharmacokinetic factors influencing drug therapy in the aged.
    Schumacher GE
    Am J Hosp Pharm; 1980 Apr; 37(4):559-62. PubMed ID: 6990755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized prospective controlled study of the metabolism and hepatotoxicity of halothane in humans.
    Cousins MJ; Gourlay GK; Knights KM; Hall PD; Lunam CA; O'Brien P
    Anesth Analg; 1987 Apr; 66(4):299-308. PubMed ID: 3565792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effect of cimetidine on drug oxidation (antipyrine and diazepam) vs. conjugation (acetaminophen and lorazepam): prevention of acetaminophen toxicity by cimetidine.
    Abernethy DR; Greenblatt DJ; Divoll M; Ameer B; Shader RI
    J Pharmacol Exp Ther; 1983 Mar; 224(3):508-13. PubMed ID: 6827475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extrahepatic biotransformation of halothane and enflurane.
    Blitt CD; Gandolfi AJ; Soltis JJ; Brown BR
    Anesth Analg; 1981 Mar; 60(3):129-32. PubMed ID: 7193988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of lipophilicity on drug distribution and elimination: Influence of obesity.
    Bruno CD; Harmatz JS; Duan SX; Zhang Q; Chow CR; Greenblatt DJ
    Br J Clin Pharmacol; 2021 Aug; 87(8):3197-3205. PubMed ID: 33450083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug kinetics and alcohol ingestion.
    Sellers EM; Holloway MR
    Clin Pharmacokinet; 1978; 3(6):440-52. PubMed ID: 31257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the accuracy of estimation of basic pharmacokinetic parameters by the traditional noncompartmental equations and the prediction of the steady-state volume of distribution in obese patients based upon data derived from normal subjects.
    Berezhkovskiy LM
    J Pharm Sci; 2011 Jun; 100(6):2482-97. PubMed ID: 21254063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics in the elderly.
    Crooks J; O'Malley K; Stevenson IH
    Clin Pharmacokinet; 1976; 1(4):280-96. PubMed ID: 797500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic drug metabolism in cystic fibrosis: recent developments and future directions.
    Kearns GL
    Ann Pharmacother; 1993 Jan; 27(1):74-9. PubMed ID: 8431626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of obesity on the pharmacokinetics of drugs in humans.
    Hanley MJ; Abernethy DR; Greenblatt DJ
    Clin Pharmacokinet; 2010; 49(2):71-87. PubMed ID: 20067334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.